1 report

CEMIPLIMAB IS AN INVESTIGATIONAL HUMAN, MONOCLONAL ANTIBODY TARGETING PD-##, BEING JOINTLY DEVELOPED BY SANOFI AND REGENERON.

  • Cough And Cold
  • Hospital
  • Surgery
  • France
  • Sanofi S.A.